CME Group (CME) Chief Accounting Officer Jack Tobin Receives Award, Sells Shares

What Happened

• Jack J. Tobin, MD Chief Accounting Officer of CME Group (CME), was granted 700 restricted shares on 2026-09-15 valued at $275.09 each (total ~$192,563).
• To satisfy tax-withholding obligations related to the vesting, Tobin surrendered a total of 347 shares: 44, 47 and 205 shares on 2026-09-15 at $275.09, and 51 shares on 2026-09-16 at $272.46. The surrendered shares total about $95,321. These disposals are tax withholding, not open-market sales.

Key Details

• Transaction types/codes: A = Award/Grant (700 RSUs); F = Shares surrendered for tax withholding (347 shares).
• Grant date: 2026-09-15 (700 RSUs at $275.09; total value ~$192,563).
• Withholding dates/prices: 2026-09-15 — 44, 47 and 205 shares at $275.09; 2026-09-16 — 51 shares at $272.46. Total withheld ≈347 shares (~$95,321).
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes: Grant is restricted stock under the CME Group Omnibus Stock Plan, vesting in four equal annual installments subject to continued service (F1). Shares were surrendered to the issuer to satisfy tax withholding on vesting (F2).
• Filing timeliness: No late filing indicated (transaction reported on Form 4 filed 2026-09-17 for 2026-09-15 activity).

Context

• This was a compensation grant (restricted stock) with routine share surrender to cover taxes — common for equity-based compensation and not the same as a voluntary open-market sale.
• The award vests over four years, so remaining shares from the grant will vest gradually subject to service.
• Codes: A = award/grant; F = tax withholding (surrendered shares). This activity is informational and does not by itself indicate a change in insider sentiment.